Cognitive disorders in AIDS: Clinical, virological and neuroradiological aspects;Troubles cognitifs du SIDA: Aspects cliniques, virologiques et neuroradiologiques

Revue Neurologique

Volumn 154, Issue 12, 1998, Pages 843-849

  Stankoff, B ^a   Suarez, S ^a   Rosemblum, O ^a   Conquy, L ^a   Turell, E ^a   Bricaire, F ^a   Coutellier, A ^a   Calvez, V ^a   Lacomblez, L ^a   Tourbah, A ^a,b   Lubetzki, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMNESIA; ANTIVIRAL ACTIVITY; CEREBROSPINAL FLUID; COGNITIVE DEFECT; HUMAN; LEUKOENCEPHALOPATHY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOMOTOR DISORDER; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAIN; CEREBROSPINAL FLUID; COGNITION DISORDERS; DNA, VIRAL; HUMANS; MAGNETIC RESONANCE IMAGING; RETROVIRIDAE;

EID: 0032437906     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. ARTIGAS J., GROSSE G., NIEDOBITEK F. (1990). Vacuolar myelopathy in AIDS: a morphological study. Pathol. Res. Prac. 186 : 228-237.
2. BACELLAR H., MUNOZ A., MILLER E., COHEN B., BESLEY D., SELNES O.A., BECKER J.T., MCARTHUR J.C. (1994). Temporal trends in the incidence of HIV 1 related neurological diseases: multicenter AIDS cohort study, 1985-1992 Neurology, 44: 1892-1900.
3. BELL J.E., BUSUTTIL A., IRONSIDE J.W., REBUS S., DONALDSON Y.K., SIMMONDS P., PEUTHERER J.F. (1993). Human immunodeficiency virus and the brain: investigation of virus load and neuropathological changes in pre-AIDS subjects. J Infect Dis, 168: 818-824.
4. BERGMAN M., GULLOTTA F., KUCHELMEISTER K., MASINI T., ANGELI G. (1993). AIDS myelopathy: a neuropathological study. Pathol Res Prac, 189: 58-65.
5. BREW B.J., PEMBERTON L., CUNNIGHAM P., LAW M.G. (1997). Levels of immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis, 175: 963-966.
6. CINQUE P., SCARPELLINI P., VAGO L., LINDE A., LAZZARIN A. (1997). Diagnosis of central nervous system complications in HIV infected patients: cerebro-spinal fluid analysis by the polymerase chain reaction. AIDS, 11: 1-17.
7. CHIODI F., KEYS B., ALBERT J. HAGBERG L., LUNDEBERG J., UHLEN M., FENYO E.M., NORKRANS G. (1992). Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol, 30: 1768-1771.
8. CONRAD A.J., SCHMID P., SYNDULKO K., SYNGER E.J., NAGRA R.M., RUSSEL J.J., TOURTELOTTE W.W., (1996). Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurological abnormalities. J. Acquired Immun Defic Syndr, 5: 797-803.
9. CORDOLIANI Y.S., SARRAZIN J.L., SOULIE D., LEVÊQUE C. (1997). Imagerie des complications neurologiques du SIDA. EMC, 31-661-B-10.
10. ELLIS R., HSIA K., SPECTOR S., NELSON J., HEATON R., WALLACE M., ABRAMSON I., ATKINSON J., GRANT I., MC CUTCHAN A. (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol, 42: 679-688.
11. GISSLEN M., NORKRANS G., SVENNERHOLM B., HAGBERG L., (1997). The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J. Infectious diseases, 175 (2), 434-7.
12. GOUDREAU G., CARPENTER S., BEAULIEU N., JOLICŒUR P. (1996). Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of myelin basic protein gene promoter. Nature Med, 2: 655-661.
13. GRAY F., GENY C., DOURNON E., FENELON G., LIONNET F., GHERARDI R. (1991). Neuropathological evidence that zidovudine reduces incidence of HIV. infection. Lancet, 337: 852-853.
14. GRAY F., LESCS M., KEOHANE C., PARAIRE F., MARC B., DURIGON M., GHERARDI R. (1992). Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non AIDS cases. J Neuropath Exp Neurol, 51: 177-185.
15. HENIN D., SMITH T. W., DE GIROLAMI U., SUGHAYER M., HAUW J.J. (1992). Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. Hum Pathol, 23: 1106-1114.
16. JANSSEN R.S., SAYKIN A.J., KAPLAN J.E., SPIRA T.J., PINSKY P.F., SPREHN G.C., HOFFMAN J. C., MAYER W.B. Jr., SHONBERGER L.B. (1988). Neurological complications of immunodeficiency virus infection in patients with lymphoadenopathy syndrome. Ann Neurol, 23: 49-55.
17. JANSSEN R.S. and the working group of the American Academy of Neurology AIDS task force (1991). Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type 1 (HIV 1) infection. Neurology, 41: 778-785.
18. KAMIN S., PETITO C.K. (1991). Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients. Hum Pathol, 22: 816-824.
19. KIEBURTZ K.D., KETONEN L., ZETTELMAYER A.E., A.E., KIDO D., CAINE E.D., SIMON J.H. (1990). Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol, 47: 643-645.
20. LAZARINI F., SEILHEAN D., ROSENBLUM O., SUAREZ S., CONQUY L., UCHIHARA T., SAZDOVITCH V., MOKHTARI K., MAISONOBE T., BOUSSIN F., KATLAMA C., BRICAIRE F., DUYCKAERTS C., HAUW J.J. (1997). Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and non demented patients with acquired immunodeficiency syndrome. J Neurovirol, 3: 299-303.
21. LEVY R.M., ROSEMBLUM S., PERRET L.V. (1986). Neuroradiological findings in AIDS: a review of 200 cases. AJR, 147: 977-983.
22. LEVY R.M., BREDESEN D.E. (1988). Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune defic Syndr, 1: 41-64.
23. LUBETZKI C., DUBARD T., SUAREZ S., KATLAMA C., TURELL E., CALVEZ E. (1997). Cerebrospinal fluid HIV load and AIDS dementia. Neurology, 48, 3: A387.
24. MC ARTHUR J.C. (1987). Neurological manifestations of AIDS. Medecine (Baltimore), 66: 407-437.
25. MC ARTHUR J.C., COHEN B.A., SELNES O.A., KUMAR A.J., COOPER K., MC ARTHUR J.H., SOUCY G., CORNBLATH D.R., CHMIEL J.S., WANG M.C., (1989). Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results of the multicenter AIDS cohort study. Ann Neurol, 26: 601-611.
26. MC ARTHUR J.C., HOOVER D.R., BACELLAR H., MILLER E.N., COHEN B.A., BECKER J.T., GRAHAM N.M., MC ARTHUR J.H., SELNES O.A., JACOBSON L.P. (1993). Dementia in AIDS patients. Incidence and risk factors. Neurology, 43: 2245-2252.
27. MC ARTHUR J.C., MC CLERNON D., CRONIN M., NANCE-SPROSON T., SAAH A., ST CLAIR M., LANIER R. (1997). CSF, HIV, RNA: relationship between human immunodeficiency virus associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol, 42: 689-698.
28. MAYEUX R., STERN Y., TANG M.X., TODAK G., MARDER K., SANO M., RICHARDS M., STEIN Z., EHRHARDT A.A., GORMAN J.M. (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology, 43: 176-182.
29. MELLORS J.W., KINSLEY L.A., RINALDO C.R., TODD J.A., HOO B.S., KOKKA R.P., GUPTA P., (1995). Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med, 122: 573-579.
30. MEYERHOFF D.J., WEINER M.W., FEIN G. (1996). Deep gray matter structures in HIV infection: a proton MR spectroscopy study. AJNR, 17: 973-978.
31. NAVIA B.A., JORDAN B.D., PRICE R.W. (1986). The AIDS dementia complex: I. Clinical features. Ann Neurol, 19: 517-524.
32. PETITO C.K., NAVIA B.A., CHO E.S., JORDAN B.D., GEORGE D.C., PRICE R.W. (1985). Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Eng J Med, 312: 874-879.
33. PORTEGIES P., DE GANS J., LANGE J.M.A., DERIX M.M., SPEELMAN H., BAKKER M., DANNER S.A., GOUDSMIT J., (1989). Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J, 299: 819-821.
34. ROSEMBLUM M., SCHECK A.C., CRONIN K., BREW B.J., KHAN A., PAUL M., PRICE R.W. (1989). Dissociation of AIDS-related vacuolar myelopathy and productive HIV infection of the spinal cord. Neurology, 39: 892-896.
35. ROYAL W., UPDIKE M., SELNES O.A. (1991). HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology, 41: 1905-1910.
36. SAAG M.S., HOLODNIY M., KURITZKES D.R., O'BRIAN W.A., COOMBS R., POSCHER M.E., JACOBSEN D.M., SHAW G.M., RICHMAN D.D., VOLBEROING P.A. (1995). HIV viral load markers in clinical practice. Nature Med. 2: 625-629.
37. SCHMID P., CONRAD A., SYNDULKO K., SINGER E.J., HANDLEY D., LI X., TAO G., FAHI-CHANDON B., TOURTELOTTE W. (1994). Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurological abnormalities. J Aquir Immune Defic Syndr, 7, 777-788.
38. SELNES O.A., MILLER E., MCARTHUR J.C., GORDON B., MUNOZ A., SHERIDAN K., FOX R., SAAH A.J. (1990). HIV infection: no evidence of cognitive decline during the asymptomatic stages. Neurology, 40: 204-208.
39. SEINES O.A., MCARTHUR J.C. ROYAL W., UPDIKE M.L., NANCE-SPROSON T., CONCHA M., GORDON B., SOLOMON L., VLAHOV D., (1992). HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology, 42: 1924-1930.
40. SIDTIS J.J., GATSONIS C., PRICE R.W., SINGER E.J., COLLIER A.C., RICHMAN D.D., HIRSCH M.S., SCHAERF F.W., FISCHL M.A., KIEBURTZ K., SIMPSON D., KOCH M.A., FEINBERG J., DAFNI R., AIDS clinical trial group. (1993). Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. Ann Neurol, 33: 343-349.
41. SNIDER W.D., SIMPSON D.M., NIELSEN S., GOLD J.W., METROKA C.E., POSNER J.B. (1983). Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol, 14: 403-418.
42. STANKOFF B., TOURBAH A., SUAREZ S., STIEVENART J.L., CONQUY L., ROSENBLUM O., TURELL E., BRICAIRE F., CALVEZ V., LYON-CAEN O., CABANIS E., LUBETZKI C. (1997). Proton magnetic resonance spectroscopy in patients with AIDS dementia: a longitudinal study. J Neurol Sci, suppl. vol. 150, S4.
43. SUAREZ S., CONQUY L., ROSENBLUM O., STANKOFF B., SEILHEAN D., TURELL E., PILLON B., DEWEER B., LAZARINI F., COUTELLIER A., BRICAIRE F., LUBETZKI C., HAUW J.J., DUBOIS B. Subcortical pattern of cognitive impairment in AIDS patients with and without dementia (soumis pour publication).
44. TARTAGLIONE T.A., COLLIER A.C., COOMBS R.W., OPHEIM K.E., CUMMINGS D.K., MACKAY S.R., BENEDETTI J., COREY L., (1991). Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long term zidovudine therapy. Arch Neurol, 48: 695-699.
45. TRACEY I., CARR C.A., GUIMARAES A.R., WORTH J.L., NAVIA B.A., GONZALES R.G. (1996). Brain choline containing compounds are elevated in HIV positive patients before the onset of AIDS dementia complex: a proton magnetic spectroscopy study. Neurology, 46: 783-788.
46. VAN DER KNAPP M.S., VALK J. (1995). Acquired immunodeficiency syndrome. In: magnetic resonance of myelin, myelination and myelin disorders, 2nd ed., Springer Verlag, Berlin, Heidelberg, 327-337.
47. VION-DURY J., CONFORT-GOUNY S., NICOLI F., DHIVER C., GASTAUT J.A., GASTAUT J.L., COZZONE P.J. (1994). Localized brain MRS metabolic patterns in HIV related encephalopathies. CR Acad Sci Paris, Sciences de la vie/life sdences, 317: 833-840.
48. VION-DURY J., NICOLI F., SALVAN A.M., CONFORT-GOUNY S., DHIVER C., COZZONE P.J. (1995). Reversal of brain metabolic alteration with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet, 8941: 60-61.